In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy.

Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P. · 2003

Read In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. by Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P. (2003) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1241724.txt.

Introduction

Latini and co-authors tested a plastic softener in newborn cord blood in 2003. DEHP is the most common softener in flexible PVC plastic. It is found across the environment. No data covered its risks in pregnancy or newborns.

Cord blood from 84 newborns was tested with sensitive chromatography. DEHP or its breakdown product appeared in 77 percent of samples. Traces of either chemical showed in 88 percent overall. Mean DEHP concentration was 1.19 in the reported units. Latini links those levels to pregnancy duration in the analysis. It appeared in Environmental Health Perspectives in 2003.

Catalog record

CREATORLatini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P.
YEAR2003
COLLECTIONPAPERS
FORMATTXT
FILE SIZE9 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1241724

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy.

By Giuseppe Latini, Claudio De Felice, Giuseppe Presta, Antonio Del Vecchio, Irma Paris, Fabrizio Ruggieri, Pietro Mazzeo

Published in: Environmental Health Perspectives

DOI: 10.1289/ehp.6202

ABSTRACT

Abstract

Di-(2-ethylhexyl)phthalate (DEHP), the most commonly used plasticizer in flexible polyvinylchloride formulations, is a ubiquitous environmental contaminant. To date, no information exists on the potential health hazards from exposure to DEHP and/or its main metabolite, mono-(2-ethylhexyl)phthalate (MEHP), in high-risk conditions, such as pregnancy and during the neonatal period. The aim of this study was to evaluate prenatal exposure to DEHP and/or MEHP and its possible biologic effects. We measured serum DEHP and MEHP concentrations in the cord blood of 84 consecutive newborns by high-performance liquid chromatography. Relationships between DEHP/MEHP and infant characteristics were tested using Fisher's exact test, unpaired t-tests, and univariate linear regression analyses, and significant differences on univariate analysis were evaluated using multiple logistic regression analysis. We found detectable cord blood DEHP and/or MEHP concentrations in 88.1% of the samples. Either DEHP or MEHP was present in 65 of 84 (77.4%) of the examined samples. Mean concentrations of DEHP and MEHP were 1.19 +/- 1.15 microg/mL [95% confidence interval (CI), 0.93-1.44, range = 0-4.71] and 0.52 +/- 0.61 microg/mL (95% CI, 0.39-0.66, range = 0-2.94), respectively. MEHP-positive newborns showed a significantly lower gestational age compared with MEHP-negative infants (p = 0.033). Logistic regression analysis results indicated a positive correlation between absence of MEHP in cord blood and gestational age at delivery (odds ratio = 1.50, 95% CI, 1.013-2.21; p = 0.043). These findings confirm that human exposure to DEHP can begin in utero and suggest that phthalate exposure is significantly associated with a shorter pregnancy duration.

FULL TEXT

The Full Text of this article is available as a PDF (109.7 KB).

SELECTED REFERENCES

These references are in PubMed. This may not be the complete list of references from this article.

Read the complete text